Survival of de novo acute myeloid leukemia at MD Anderson (1970-2017)... | Download Scientific Diagram
Diagnosis and treatment of therapy-related acute myeloid leukemia - ScienceDirect
Personalizing initial therapy in acute myeloid leukemia: incorporating novel agents into clinical practice - Christin B. DeStefano, Christopher S. Hourigan, 2018
IJMS | Free Full-Text | Application of High Throughput Technologies in the Development of Acute Myeloid Leukemia Therapy: Challenges and Progress
Haematologica August 2021
How do doctors tell de novo acute myeloid leukemia (de novo AML), AML-MRC, and tAML apart? - YouTube
A single-cell survey of cellular hierarchy in acute myeloid leukemia | Journal of Hematology & Oncology | Full Text
Decitabine shows comparable OS to standard induction chemotherapy and better safety in patients with AML
Acute Myeloid Leukemia | Oncohema Key
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1 - Modern Pathology
Secondary acute myeloid leukemia
Recurrent mutation groups in de novo AML. Genes recurrently mutated in... | Download Scientific Diagram
Challenging the concept of de novo acute myeloid leukemia: Environmental and occupational leukemogens hiding in our midst - ScienceDirect
Recently approved therapies in acute myeloid leukemia: A complex treatment landscape - ScienceDirect
Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities | Haematologica
Secondary vs de novo acute myeloid leukemia
Trends in acute myeloid leukaemia in Western Australia over time: Improved outcomes with contemporary management | Tasman Medical Journal
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06 | Haematologica
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia | Leukemia
What is AML? | MDS Foundation
Secondary acute myeloid leukemia
Characterization and Prognosis of Secondary Acute Myeloid Leukemia in an Asian Population: AML With Antecedent Hematological Disease Confers Worst Outcomes, Irrespective of Cytogenetic Risk | Anticancer Research
